anti-VEGF neutralizing nanobodies (Abzyme)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-VEGF neutralizing nanobodies (Abzyme)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsChoroidal Neovascularization
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbzyme Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbzyme Therapeutics Llc
Active IndicationsN/A
Inactive IndicationsChoroidal Neovascularization

Other Information

ATC CodeN/A
Related LinksN/A